Evidence map›Paper›PMID 39720166›Full record

ArticleFrontiers in bioengineering and biotechnology2024

Enhancing the reverse transcriptase function in Taq polymerase via AI-driven multiparametric rational design.

Yulia E Tomilova, Nikolay E Russkikh, Igor M Yi, Elizaveta V Shaburova, Viktor N Tomilov, Galina B Pyrinova, Svetlana O Brezhneva, Olga S Tikhonyuk, Nadezhda S Gololobova, Dmitriy V Popichenko and 7 more

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yulia E TomilovaAO Vector-Best, Novosibirsk, Russia.
Nikolay E RusskikhAcademGene LLC, Novosibirsk, Russia.
Igor M YiAcademGene LLC, Novosibirsk, Russia.
Elizaveta V ShaburovaMSU Institute for Artificial Intelligence, Lomonosov Moscow State University, Moscow, Russia.
Viktor N TomilovSibEnzyme Ltd., Novosibirsk, Russia.
Galina B PyrinovaAO Vector-Best, Novosibirsk, Russia.
Svetlana O BrezhnevaAO Vector-Best, Novosibirsk, Russia.
Olga S TikhonyukAO Vector-Best, Novosibirsk, Russia.
Nadezhda S GololobovaAO Vector-Best, Novosibirsk, Russia.
Dmitriy V PopichenkoAO Vector-Best, Novosibirsk, Russia.
Maxim O ArkhipovAO Vector-Best, Novosibirsk, Russia.
Leonid O BryzgalovAO Vector-Best, Novosibirsk, Russia.
Evgeniy V BrennerAO Vector-Best, Novosibirsk, Russia.
Anastasia A ArtyukhAO Vector-Best, Novosibirsk, Russia.
Dmitry N ShtokaloAcademGene LLC, Novosibirsk, Russia.
Denis V AntonetsMSU Institute for Artificial Intelligence, Lomonosov Moscow State University, Moscow, Russia.
Mikhail K IvanovAO Vector-Best, Novosibirsk, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5'- 3' exonuclease activity, effective deoxyuracyl incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates. Our objective was to use AI-driven rational design combined with multiparametric wet-lab analysis to identify and validate Taq polymerase mutants with an optimal combination of these properties. Methods: The experimental procedure was conducted in several stages: 1) On the basis of a foundational paper, we selected 18 candidate mutations known to affect RTase activity across six sites. These candidates, along with the wild type, were assessed in the wet lab for multiple properties to establish an initial training dataset. 2) Using embeddings of Taq polymerase variants generated by a protein language model, we trained a Ridge regression model to predict multiple enzyme properties. This model guided the selection of 14 new candidates for experimental validation, expanding the dataset for further refinement. 3) To better manage risk by assessing confidence intervals on predictions, we transitioned to Gaussian process regression and trained this model on an expanded dataset comprising 33 data points. 4) With this enhanced model, we conducted an Results and Discussion: This iterative, data-driven strategy ultimately led to the identification of 18 enzyme variants that exhibited markedly improved RTase activity while maintaining a favorable balance of other key properties. These enhancements were generally accompanied by lower K

Indexed as

bioengineeringfunction enhancementmachine learningprotein language modelrational designreverse transcriptionTaq polymerase

Identifiers

PMID39720166
PMCPMC11666352

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.